Ubiquitin ligases: cell-cycle control and cancer

KI Nakayama, K Nakayama - Nature Reviews Cancer, 2006 - nature.com
A driving force of the cell cycle is the activation of cyclin-dependent kinases (CDKs), the
activities of which are controlled by the ubiquitin-mediated proteolysis of key regulators such as …

Regulation of the cell cycle by SCF-type ubiquitin ligases

KI Nakayama, K Nakayama - Seminars in cell & developmental biology, 2005 - Elsevier
Regulation of the cell cycle is dependent on protein degradation by the ubiquitin–proteasome
system. Two major ubiquitin ligases, the anaphase-promoting complex or cyclosome (APC/…

Regulation of the cell cycle at the G1–S transition by proteolysis of cyclin E and p27Kip1

KI Nakayama, S Hatakeyama, K Nakayama - Biochemical and biophysical …, 2001 - Elsevier
The transition from G 1 phase to S phase of the mammalian cell cycle is controlled by many
positive and negative regulators, among which cyclin E and p27 Kip1 , respectively, undergo …

[PDF][PDF] Foxo3a is essential for maintenance of the hematopoietic stem cell pool

…, K Hosokawa, H Nakauchi, K Nakayama, KI Nakayama… - Cell stem cell, 2007 - cell.com
Hematopoietic stem cells (HSCs) are maintained in an undifferentiated quiescent state within
a bone marrow niche. Here we show that Foxo3a, a forkhead transcription factor that acts …

Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7

…, F Okumura, K Nakayama, KI Nakayama - The EMBO …, 2004 - embopress.org
The F‐box protein Skp2 mediates c‐Myc ubiquitylation by binding to the MB2 domain.
However, the turnover of c‐Myc is largely dependent on phosphorylation of threonine‐58 and …

[HTML][HTML] U box proteins as a new family of ubiquitin-protein ligases

…, M Yada, M Matsumoto, N Ishida, KI Nakayama - Journal of Biological …, 2001 - ASBMB
The U box is a domain of ∼70 amino acids that is present in proteins from yeast to humans.
The prototype U box protein, yeast Ufd2, was identified as a ubiquitin chain assembly factor …

SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

…, J Settleman, SP Gygi, AL Kung, T Look, KI Nakayama… - Nature, 2011 - nature.com
The effective use of targeted therapy is highly dependent on the identification of responder
patient populations. Loss of FBW7, which encodes a tumour-suppressor protein, is frequently …

Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence

…, S Iida, H Tahara, K Nakayama, KI Nakayama… - Nature cell …, 2006 - nature.com
The p16 INK4a cyclin-dependent kinase inhibitor has a key role in establishing stable G1
cell-cycle arrest through activating the retinoblastoma (Rb) tumour suppressor protein pRb 1 , …

[HTML][HTML] The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription

…, P Hydbring, I Weidung, K Nakayama, KI Nakayama… - Molecular cell, 2003 - cell.com
The transcription regulatory oncoprotein c-Myc controls genes involved in cell growth,
apoptosis, and oncogenesis. c-Myc is turned over very quickly through the ubiquitin/proteasome …

Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ

…, H Nagahama, S Ohno, S Hatakeyama, KI Nakayama - Nature, 2002 - nature.com
Protein kinase C (PKC), which comprises 11 closely related isoforms, has been implicated
in a wide variety of cellular processes, such as growth, differentiation, secretion, apoptosis …